U.S. Markets open in 7 hrs 31 mins

Auxly Cannabis Group Inc. (CBWTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2525-0.0135 (-5.08%)
At close: 3:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2660
Open0.2950
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.2510 - 0.2950
52 Week Range0.0800 - 0.5240
Volume3,602,126
Avg. Volume1,750,362
Market Cap175.781M
Beta (5Y Monthly)2.53
PE Ratio (TTM)N/A
EPS (TTM)-0.0750
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Auxly Announces Upsized Bought-Deal Public Offering to $17.5 Million

    NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (“Auxly” or the “Company”) (TSXV: XLY) (OTCQX: CBWTF) is pleased to announce that it has entered into a revised agreement with ATB Capital Markets Inc. and Cantor Fitzgerald Canada Corporation, as co-lead underwriters and joint bookrunners, together with a syndicate of underwriters (collectively, the “Underwriter”), to increase the size of the previously announced bought-deal short-form prospectus offering of units of the Company (the “Units”) to 47,300,000 Units at a price of $0.37 per Unit for aggregate gross proceeds of $17,501,000 (the “Offering”). Each Unit shall be comprised of one common share of the Company (each a "Common Share") and one-half of one Common Share purchase warrant of the Company (each whole warrant, a "Warrant"). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of $0.46 at any time up to 36 months from closing of the Offering. The Company has granted the Underwriter an option (the “Underwriter’s Option”) to increase the size of the Offering by up to an additional number of Units, and/or the components thereof, that in aggregate would be equal to 15% of the total number of Units to be issued under the Offering, exercisable at any time and from time to time up to 30 days following the closing of the Offering. The net proceeds from the Offering will be used for working capital and general corporate purposes. The closing of the Offering is expected to occur on or about the week of February 10, 2021 (the “Closing”), or such later or earlier date as the Underwriter and the Company may agree upon, and is subject to the Company receiving all necessary regulatory approvals, including the approval of the necessary securities regulatory authorities. The Units will be offered by way of a short form prospectus to be filed in those provinces of Canada as the Underwriter may designate pursuant (except Quebec) to National Instrument 44-101 – Short Form Prospectus Distributions and may be offered in the United States on a private placement basis pursuant to an appropriate exemption from the registration requirements under applicable U.S. law. No securities regulatory authority has either approved or disapproved of the contents of this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws. ON BEHALF OF THE BOARD "Hugo Alves" CEO About Auxly Cannabis Group Inc. (TSX.V: XLY)Auxly is an international cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the medical, wellness and adult-use markets. Auxly's experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market. Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/. Investor Relations:For investor enquiries please contact our Investor Relations Team:Email: IR@auxly.comPhone: 1.833.695.2414 Media Enquiries (only): For media enquiries or to set up an interview please contact:Email: press@auxly.com Notice Regarding Forward Looking Information: This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the receipt of the necessary regulatory approvals for the Offering, the timing and proposed completion of the Offering, the expected use of proceeds of the Offering by the Company; the pricing of the Offering , future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting Auxly in particular and the cannabis industry generally. A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information included in this release including, but not limited to: whether the Company can complete the Offering on the anticipated terms and timeline; whether the Company can obtain regulatory approval of the Offering on the proposed terms and timeline; and general economic, financial market, legislative, regulatory, competitive and political conditions in which the Company operates will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2019. New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on Auxly’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking information in this news release is based on information currently available and what management believes are reasonable assumptions. The purpose of forward-looking information is to provide the reader with a description of management's expectations, and such forward-looking information may not be appropriate for any other purpose. Readers should not place undue reliance on forward-looking information contained in this news release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

  • GlobeNewswire

    Auxly Announces $15 Million Bought-Deal Public Offering

    NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (“Auxly” or the “Company”) (TSXV: XLY) (OTCQX: CBWTF) is pleased to announce that it has entered into an agreement pursuant to which ATB Capital Markets Inc. and Cantor Fitzgerald Canada Corporation, as co-lead underwriters and joint bookrunners, together with a syndicate of underwriters (collectively, the “Underwriters”), will purchase 40,550,000 Units of the Company (the “Units”), on a bought-deal basis at a price per Unit of $0.37 (the “Issue Price”) for gross proceeds of $15,003,500 (the "Offering"). Each Unit shall be comprised of one common share of the Company (each a "Common Share") and one-half of one Common Share purchase warrant of the Company (each whole warrant, a "Warrant"). Each Warrant shall entitle the holder thereof to purchase one Common Share at an exercise price of $0.46 at any time up to 36 months from closing of the Offering. The Company has granted the Underwriters an option (the “Underwriters’ Option”) to increase the size of the Offering by up to an aggregate number of Units, and/or the components thereof, equal to 15% of the total number of Units issued under the Offering, such Underwriters’ Option being exercisable at any time and from time to time up to 30 days following the closing of the Offering. The net proceeds from the Offering will be used for working capital and general corporate purposes. The closing of the Offering is expected to occur on or about February 10, 2021 (the “Closing”), or such later or earlier date as the Underwriters and the Company may agree upon, and is subject to the Company receiving all necessary regulatory approvals, including the approval of the necessary securities regulatory authorities, including the TSX Venture Exchange. The Units will be offered by way of a short form prospectus to be filed in those provinces of Canada as the Underwriters may designate (except Quebec) pursuant to National Instrument 44-101 – Short Form Prospectus Distributions and may be offered in the United States on a private placement basis pursuant to an appropriate exemption from the registration requirements under applicable U.S. law. No securities regulatory authority has either approved or disapproved of the contents of this news release. This news release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended, and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from U.S. registration requirements and applicable U.S. state securities laws. ON BEHALF OF THE BOARD "Hugo Alves" CEO About Auxly Cannabis Group Inc. (TSX.V: XLY)Auxly is an international cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the medical, wellness and adult-use markets. Auxly's experienced team of industry first-movers and enterprising visionaries have secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading research and development infrastructure in order to create trusted products and brands in an expanding global market. Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/. Investor Relations:For investor enquiries please contact our Investor Relations Team:Email: IR@auxly.comPhone: 1.833.695.2414 Media Enquiries (only): For media enquiries or to set up an interview please contact:Email: press@auxly.com Notice Regarding Forward Looking Information: This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the receipt of the necessary regulatory approvals for the Offering, the timing and proposed completion of the Offering, the expected use of proceeds of the Offering by the Company; the pricing of the Offering, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting Auxly in particular and the cannabis industry generally. A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information included in this release including, but not limited to: whether the Company can complete the Offering on the anticipated terms and timeline; whether the Company can obtain regulatory approval of the Offering on the proposed terms and timeline; and general economic, financial market, legislative, regulatory, competitive and political conditions in which the Company operates will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2019. New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on Auxly’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking information in this news release is based on information currently available and what management believes are reasonable assumptions. The purpose of forward-looking information is to provide the reader with a description of management's expectations, and such forward-looking information may not be appropriate for any other purpose. Readers should not place undue reliance on forward-looking information contained in this news release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

  • Auxly in Top Spot for 2.0 Products
    GlobeNewswire

    Auxly in Top Spot for 2.0 Products

    Photo 1 Canadian Cannabis 2.0 sales for 2020, by category, according to Headset Canadian Insights Photo 2 Canadian Cannabis 2.0 sales for 2020, by Licensed Producer, according to Headset Canadian Insights Headset data confirms Auxly as the top-selling licensed producer of Cannabis 2.0 products for 2020, with a 14% share of the total 2.0 market1 A Media Snippet accompanying this announcement is available by clicking on the image or link below: TORONTO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY)1 (“Auxly” or the “Company”), a leading consumer packaged goods company in the cannabis products market, is pleased to announce that the Company achieved the #1 market share position for Cannabis 2.0 products in 2020, as confirmed by Headset Canadian Insights data. 2020 was the first full year for the sale of Cannabis 2.0 products, which is generally understood to consist of vapes, edibles, beverages, extracts and topicals. Despite not participating in every 2.0 category, Auxly’s 19.2% share of the total vape market and 12% share of the total edibles market propelled the Company to the #1 spot in overall 2.0 sales for the year. Auxly saw robust sales growth quarter over quarter, especially in its vape product offering – the largest 2.0 category – securing 23% of the national vape market share in the fourth quarter2. “We are extremely proud to be the #1 LP for Cannabis 2.0 in Canada,” said Hugo Alves, CEO, Auxly. “The amount of support and overwhelmingly positive feedback we have received from Canadian retail consumers throughout this first year of sales has been tremendous. Our commitment to delivering high-quality, differentiated and innovative cannabis products has clearly struck a chord with Canadians and our entire team remains highly motivated to continue our growth trajectory as we start a new year.” Additional Operational Highlights for 2020 included: One of the first LPs to market with 2.0 products, with initial shipments made to nine provinces.Listed as the #1 LP in national vape sales in the fourth quarter of 2020, with 23% market share.During the third quarter, successfully completed the second-floor expansion at its Dosecann facility located in Prince Edward Island, enabling increased production, fulfillment rates and sale of cannabis products.Auxly continued to introduce new and exciting cannabis products to the market throughout the year, with the launch of the Back Forty brand, Foray Hard Maple Caramels, Dosecann Capsules, Kolab Project Cherry Cola Pop milk chocolates and Kolab Project 232 Series live terpene vape cartridges.Expansion into Cannabis 1.0 with the launch of Robinson’s premium dried flower and Kolab Project Grower Series collaborations with Lotus Cannabis Co. and Safari Flower Co.Auxly’s joint venture, Sunens Farms Inc., received its standard cultivation licence for the first phase of its greenhouse project. Looking ahead into 2021, Auxly continues to focus its efforts on innovation and executional excellence as it solidifies its national footprint with its consumer brands Back Forty, Dosecann, Foray, Kolab Project and Robinsons. ON BEHALF OF THE BOARD "Hugo Alves” CEO About Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) Auxly is an international cannabis company dedicated to bringing innovative, effective, and high-quality cannabis products to the medical, wellness and adult-use markets. Auxly's experienced team of industry first-movers and enterprising visionaries has secured a diversified supply of raw cannabis, strong clinical, scientific and operating capabilities and leading product research and development infrastructure in order to create trusted products and brands in an expanding global market. Learn more at www.auxly.com and stay up to date at Twitter: @AuxlyGroup; Instagram: @auxlygroup; Facebook: @auxlygroup; LinkedIn: company/auxlygroup/. Investor Relations: For investor enquiries please contact our Investor Relations Team: Email: IR@auxly.comPhone: 1.833.695.2414 Media Enquiries (only): For media enquiries or to set up an interview please contact:Email: press@auxly.com Notice Regarding Forward Looking Information: This news release contains certain "forward-looking information" within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward looking information includes, but is not limited to: the Company’s execution of its product development and commercialization strategy; consumer preferences; political change, future legislative and regulatory developments involving cannabis and cannabis products; and competition and other risks affecting the Company in particular and the cannabis industry generally. A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: the Company’s subsidiaries and partners are able to maintain the necessary regulatory authorizations to conduct business; there is acceptance and demand for current and future Company products by consumers and provincial purchasers; and general economic, financial market, regulatory and political conditions in which the Company operates will remain the same. Additional risk factors are disclosed in the annual information form of the Company for the financial year ended December 31, 2019 dated May 13, 2020. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party industry sources, the accuracy of which has not been verified by Auxly. Readers should not place undue reliance on forward-looking information contained in this release. The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 1 Headset Canadian Insights, Total Canadian Cannabis 2.0 sales, January 1, 2020 - December 31, 20202 Headset Canadian Insight, Canadian Vape sales, October 1, 2020 – December 31, 2020 Photos accompanying this announcement are available at:https://www.globenewswire.com/NewsRoom/AttachmentNg/1d1fd8d7-9d6d-4c64-8a4b-1ad9d09eef7bhttps://www.globenewswire.com/NewsRoom/AttachmentNg/0ebb1305-5bc3-43ce-84ee-c14f25d73b73